Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas

NCT01788189 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

B-cell Lymphoma

Interventions

DRUG: Lenalidomide

Sponsor

University Hospital, Essen

Collaborators

[object Object]